Blogs about: X North East
Featured Blog
AgaMatrix, Inc.: Series C $23.7M
AgaMatrix (Salem, NH) maker of blood glucose monitoring systems that provide results to help users better manage their diabetes closed a $23.7M Series C financing. Participants include Ferrer Freeman … more →
OnBioVC
AgaMatrix, Inc.: Series C $23.7M
arubenstein wrote 1 year ago: AgaMatrix (Salem, NH) maker of blood glucose monitoring systems that provide results to help users b … more →
PeptImmune, Inc.: Series D $8.2M
arubenstein wrote 1 year ago: PeptImmune Inc. (Cambridge, MA) a clinical stage biotechnology company utilizing novel and proven te … more →
Pervasis Therapeutics, Inc.: Series B $9.75M
arubenstein wrote 1 year ago: Pervasis Therapeutics (Cambridge, MA) is working to regulate vascular repair and restore natural blo … more →
Aushon Biosystems, Inc.: Series B $7.0M
arubenstein wrote 1 year ago: Aushon Biosystems (Burlington, MA) provides advanced microarray technologies to life science researc … more →
Cara Therapeutics, Inc.: Series C $24M
arubenstein wrote 2 years ago: Cara Therapeutics (Tarrytown, NY) is an emerging biotechnology company focused on developing novel t … more →
Claros Diagnostics, Inc.: Series A $7.8M
arubenstein wrote 2 years ago: Claros Diagnostics (Woburn, MA) is developing a handheld disease monitoring device that allows anyon … more →
